Diagnostic approach to metastatic adenocarcinomaSivaranjini N
The document discusses the role of immunohistochemistry (IHC) in diagnosing metastatic adenocarcinoma of unknown primary origin. It outlines a 5-step sequential approach to diagnosis: [1] Determine cell lineage using major markers, [2] Cytokeratin profile, [3] Check for vimentin co-expression, [4] Check for supplemental epithelial or germ cell antigens, [5] Check for organ-specific markers. The summary focuses on common IHC markers used including cytokeratins, vimentin, S100, CD45 and discusses their diagnostic utility in determining the cell lineage and origin of metastatic cancers of unknown primary.
The document discusses the poor living conditions of cancer cells. It states that the life of a cancer cell is complex, with metabolic stress both inside and outside the cell. Cancer cells have abnormal DNA transcription and hypermethylated genes. Their energy production and biosynthesis abilities are impaired. They also have imbalanced ions and issues with nuclear and cytoplasmic membranes. Cancer cells live parasitically and are immortal and continuously proliferative, with multi-antigenic characteristics. All of these problems contribute to the complicated and problematic nature of cancer cell proliferation.
A 15-year-old boy presented with abdominal pain and a mass near his umbilicus. Ultrasound-guided fine needle aspiration of the mass was performed. Histopathology showed a high grade malignant tumor. Immunohistochemistry testing was ALK positive, indicating an ALK positive diffuse large B-cell lymphoma. This is a rare and aggressive form of lymphoma associated with poor prognosis. Further genetic testing showed a clathrin-ALK gene rearrangement, consistent with this diagnosis.
The document discusses the lifestyle of cancer cells, describing it as complicated and stressful. Cancer cells experience metabolic stress, have hypermethylated DNA that should not be transcribed, and have impaired energy production and biosynthesis. They also display characteristics like immortality and continuous proliferation. The document suggests that cancer cell renewal is transformed from normal to neoplastic by chronic inflammation from immune cells like macrophages, representing a stress response and cultural adaptation.
This study identified BRAF mutations in patients with hairy cell leukemia (HCL). The BRAF V600E mutation was present in all HCL patients tested, leading to overactive BRAF signaling and increased cell proliferation. Immunohistological and Western Blot tests found constitutive activation of the RAF-MEK-ERK pathway in HCL cells. A BRAF inhibitor reduced phosphorylation of MEK and ERK, indicating BRAF drives HCL pathogenesis. Identifying this genetic mutation improves understanding of HCL and could inform future treatment development.
This document discusses the role of cytogenetics in studying cancer and leukemia. Cytogenetics is the study of chromosomes and their abnormalities, which allows for the identification of genetic factors involved in diseases. The suppression of chromosome 9p in clear cell renal carcinoma predicts a worse prognosis, as it is associated with larger tumors and a higher risk classification. Additionally, deletions on the long arm of chromosome 20 are linked to acute myeloid leukemia and can indicate the loss of a tumor suppressor gene. Cytogenetic analysis provides important clinical information to help prevent cancer recurrence and select appropriate treatment strategies.
This study investigates how inflammatory breast cancer (IBC) cells evade anoikis, a form of programmed cell death triggered by detachment from the extracellular matrix (ECM). The researchers found that two IBC cell lines, KPL-4 and SUM149, resisted anoikis and survived when detached from ECM. Knocking down ErbB2 in KPL-4 cells or EGFR in SUM149 cells increased anoikis and decreased anchorage-independent growth. The ERK/MAPK pathway operated downstream of ErbB2/EGFR to protect the IBC cells from anoikis. Unlike in other cell types, inhibiting ERK did not increase levels of the pro-ap
The document summarizes research using chick embryo models to study cancer metastasis. It describes several advantages of the chick embryo model, including its ability to support rapid growth of xenografted human tumor cells. Several chick embryo cancer models are outlined, including models for spontaneous metastasis, analyzing tumor cell interactions with vasculature, and studying invasion and extravasation. Examples are given of studies using these models to analyze tumor growth and metastasis of various cancer cell lines and effects of potential therapeutics.
Diagnostic approach to metastatic adenocarcinomaSivaranjini N
The document discusses the role of immunohistochemistry (IHC) in diagnosing metastatic adenocarcinoma of unknown primary origin. It outlines a 5-step sequential approach to diagnosis: [1] Determine cell lineage using major markers, [2] Cytokeratin profile, [3] Check for vimentin co-expression, [4] Check for supplemental epithelial or germ cell antigens, [5] Check for organ-specific markers. The summary focuses on common IHC markers used including cytokeratins, vimentin, S100, CD45 and discusses their diagnostic utility in determining the cell lineage and origin of metastatic cancers of unknown primary.
The document discusses the poor living conditions of cancer cells. It states that the life of a cancer cell is complex, with metabolic stress both inside and outside the cell. Cancer cells have abnormal DNA transcription and hypermethylated genes. Their energy production and biosynthesis abilities are impaired. They also have imbalanced ions and issues with nuclear and cytoplasmic membranes. Cancer cells live parasitically and are immortal and continuously proliferative, with multi-antigenic characteristics. All of these problems contribute to the complicated and problematic nature of cancer cell proliferation.
A 15-year-old boy presented with abdominal pain and a mass near his umbilicus. Ultrasound-guided fine needle aspiration of the mass was performed. Histopathology showed a high grade malignant tumor. Immunohistochemistry testing was ALK positive, indicating an ALK positive diffuse large B-cell lymphoma. This is a rare and aggressive form of lymphoma associated with poor prognosis. Further genetic testing showed a clathrin-ALK gene rearrangement, consistent with this diagnosis.
The document discusses the lifestyle of cancer cells, describing it as complicated and stressful. Cancer cells experience metabolic stress, have hypermethylated DNA that should not be transcribed, and have impaired energy production and biosynthesis. They also display characteristics like immortality and continuous proliferation. The document suggests that cancer cell renewal is transformed from normal to neoplastic by chronic inflammation from immune cells like macrophages, representing a stress response and cultural adaptation.
This study identified BRAF mutations in patients with hairy cell leukemia (HCL). The BRAF V600E mutation was present in all HCL patients tested, leading to overactive BRAF signaling and increased cell proliferation. Immunohistological and Western Blot tests found constitutive activation of the RAF-MEK-ERK pathway in HCL cells. A BRAF inhibitor reduced phosphorylation of MEK and ERK, indicating BRAF drives HCL pathogenesis. Identifying this genetic mutation improves understanding of HCL and could inform future treatment development.
This document discusses the role of cytogenetics in studying cancer and leukemia. Cytogenetics is the study of chromosomes and their abnormalities, which allows for the identification of genetic factors involved in diseases. The suppression of chromosome 9p in clear cell renal carcinoma predicts a worse prognosis, as it is associated with larger tumors and a higher risk classification. Additionally, deletions on the long arm of chromosome 20 are linked to acute myeloid leukemia and can indicate the loss of a tumor suppressor gene. Cytogenetic analysis provides important clinical information to help prevent cancer recurrence and select appropriate treatment strategies.
This study investigates how inflammatory breast cancer (IBC) cells evade anoikis, a form of programmed cell death triggered by detachment from the extracellular matrix (ECM). The researchers found that two IBC cell lines, KPL-4 and SUM149, resisted anoikis and survived when detached from ECM. Knocking down ErbB2 in KPL-4 cells or EGFR in SUM149 cells increased anoikis and decreased anchorage-independent growth. The ERK/MAPK pathway operated downstream of ErbB2/EGFR to protect the IBC cells from anoikis. Unlike in other cell types, inhibiting ERK did not increase levels of the pro-ap
The document summarizes research using chick embryo models to study cancer metastasis. It describes several advantages of the chick embryo model, including its ability to support rapid growth of xenografted human tumor cells. Several chick embryo cancer models are outlined, including models for spontaneous metastasis, analyzing tumor cell interactions with vasculature, and studying invasion and extravasation. Examples are given of studies using these models to analyze tumor growth and metastasis of various cancer cell lines and effects of potential therapeutics.
This document discusses research into the role of the Bmi1 gene in tongue squamous cell carcinoma (TSCC). The study evaluated Bmi1 expression in 77 TSCC tumor samples and its impact on cancer cell migration and invasion. The results showed high Bmi1 expression in TSCC tissues and cell lines. Silencing Bmi1 using siRNA inhibited the migration and invasion of TSCC cells. Additionally, the study found that Bmi1 expression may be regulated by the C-myc oncogene and that both Bmi1 and C-myc regulate genes involved in cell proliferation and metastasis. This research provides insights into how Bmi1 contributes to TSCC development and progression.
The document discusses diffuse large B-cell lymphoma (DLBCL), its subtypes and classification. It describes how DLBCL can be categorized based on site of origin, characteristic features, association with viruses, or remain unclassified. Gene expression profiling can further distinguish DLBCL subgroups with different prognosis. The presence of MYC rearrangement or double hit lymphomas involving MYC and BCL2/BCL6 translocations predicts a very aggressive clinical outcome.
This document discusses modern treatment strategies for diffuse large B-cell lymphoma (DLBCL). It summarizes that DLBCL is molecularly distinct diseases with different biological characteristics and outcomes. Targeted therapies like ibrutinib and lenalidomide show promise for the activated B-cell (ABC) subtype of DLBCL. Monitoring circulating tumor DNA is presented as a very promising tool for early detection of treatment failure or recurrence, which can allow for pre-emptive treatment changes or early intervention.
Tumour markers can play a crucial role in detecting cancer and assessing response to therapy. They are substances produced either by tumour cells or by the body in response to cancer. Oncoproteins are proteins encoded by oncogenes which normally maintain a fine balance between cell proliferation and differentiation but become permanently activated in cancer, stimulating cell growth. Elevated levels of various oncoproteins and other tumour markers can be detected in blood and other body fluids, serving as biomarkers for early cancer detection and prediction of prognosis. Common tumour markers discussed include AFP, CEA, CA19-9, CA15-3, CA125, and proteins associated with growth factors, receptors, and cellular signalling pathways.
This document contains summaries of several topics related to immunobiology and cancer, including lymph formation and functions, inhibition of tumor-induced T cell anergy, generating cytolytic memory T cells, STAT3 activation in diffuse large B cell lymphoma, microbial control of intestinal innate immunity, spatiotemporal dynamics of Rho GTPases in cancer invasion, the role of macroH2A1 in cancer and senescence, epigenetic regulation of cancer by DNA methylation enzymes, targeting epigenetics in anticancer approaches, bladder cancer as a model for translational medicine, biology and treatment of prostate cancer, and personalized cancer medicine.
The document discusses several key hallmarks of cancer cells including evading apoptosis, achieving limitless replicative potential through telomerase activation, inducing angiogenesis, and developing the ability to invade locally and metastasize. It describes the intrinsic and extrinsic pathways of apoptosis evasion in cancer cells as well as mechanisms of telomere maintenance, angiogenesis induction, extracellular matrix degradation, vascular dissemination, and homing to distant sites.
This document summarizes the use of the nematode C. elegans as a model organism for studying human diseases. It discusses how CRISPR/Cas9 can be used to introduce disease-related mutations into C. elegans to model retinitis pigmentaria, cancer, and responses to chemotherapy. Drug screens and RNAi screens in these mutant worms have identified genetic modifiers and potential drug targets for treating human diseases. The small size, rapid life cycle, and genetic tractability of C. elegans make it a valuable pre-clinical model for validating targets and precision medicines before testing in mammalian systems.
This document discusses mature lymphoproliferative disorders. It covers their classification, stages of maturation, B-cell development and lymphomagenesis. Molecular features of lymphomas include genetic alterations, infection, antigen stimulation and immunosuppression. Chromosomal translocations can activate proto-oncogenes by juxtaposing regulatory sequences. Tumor suppressor genes are also inactivated through deletion and mutation. Somatic hypermutation may introduce genetic changes involved in lymphomagenesis.
- Compared to healthy controls, pancreatic cancer patients had significantly higher levels of total microparticles (MPs) and phosphatidylserine exposed MPs in their plasma.
- When perfused through an engineered microvessel network, only pancreatic cancer patients' plasma caused a significant number of MPs to adhere to the endothelial cells lining the vessels.
- Perfusing MPs derived from pancreatic cancer cells or cancer patients' plasma through the microvessels activated the endothelial cells, resulting in their increased release of endothelial cell-derived MPs.
This document provides an overview of neoplasia and the etiology of cancer. It discusses the three classes of carcinogenic agents: chemicals, radiant energy, and microbial agents. It describes chemical carcinogenesis as a multistep process involving initiation, promotion, and progression. Specific chemical carcinogens like polycyclic aromatic hydrocarbons and their mechanisms are explained. Radiation carcinogenesis and viral/microbial oncogenesis involving viruses like HPV, HBV, EBV, and HTLV-1 are summarized. Host defense against tumors through tumor immunity and tumor antigen classification is briefly covered.
Cancer is caused by genetic mutations from carcinogens like chemicals, radiation, and viruses. Cancer cells show uncontrolled growth, loss of contact inhibition, and altered biochemistry. Tumor markers are proteins produced by or in response to cancer that can help detect and monitor cancers. Common tumor markers include AFP for liver cancer, CEA for colorectal cancer, and PSA for prostate cancer.
Liver cancer is the fifth most common cancer and the second leading cause of cancer death globally. Hepatocellular carcinoma (HCC) represents about 90% of primary liver cancers. Major risk factors for HCC development include cirrhosis, viral hepatitis, toxins like alcohol and aflatoxins, metabolic conditions, and genetic disorders. Diagnosis involves non-invasive testing of tumor markers like AFP, AFP-L3, DCP, and imaging, or invasive biopsy. Surgical resection offers the best chance of cure for eligible early-stage patients with small tumors, while other treatments include cryosurgery, transplantation, and immunotherapy.
This document discusses biliary tract cancers including cholangiocarcinoma and gallbladder cancer. It provides information on risk factors, pathogenesis, clinical presentation, diagnostic evaluation, staging systems, and treatment options. Biliary tract cancers are generally diagnosed at late stages and have a poor prognosis. Surgical resection remains the only potentially curative treatment option, but palliative approaches are used for non-resectable disease.
Myeloid CCN3 protects against aortic valve calcifcation.pdfMafeOliveros3
This document summarizes a study that investigated the role of macrophage-derived CCN3 in the progression of calcific aortic valve disease. The study used techniques like immunofuorescence, PCR, Western blot, and ELISA to analyze CCN3 levels and interactions with other proteins in normal and calcified aortic valves. Results found CCN3 and other proteins like CD68, BMP2, and Vimentin present in calcified valves. The conclusion is that molecular biology techniques have helped further understanding of pathologies and development of diagnoses and treatments.
Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner ...home
These observations delineate the significance of immuno-modulatory circuit during calcarea carbonicamediated
tumor apoptosis. The molecular mechanism identified may serve as a platform for involving calcarea
carbonica into immunotherapeutic strategies for effective tumor regression
This document provides an overview of hepatic and pancreatic tumors. It discusses the clinical anatomy and physiology of the liver and pancreas. It describes different types of benign hepatic tumors like hemangiomas, adenomas, and focal nodular hyperplasia. For malignant hepatic tumors, it discusses hepatocellular carcinoma and cholangiocarcinoma. It covers the epidemiology, investigations, and management options for these tumors. For the pancreas, it discusses anatomy, physiology, tumor types including neuroendocrine tumors, and the management of pancreatic tumors through surgery or palliation.
The document discusses several topics related to colorectal cancer including hereditary forms, staging, treatment with surgery and targeted therapies. It presents two case studies, one with a family history of colon cancer who was found to have a genetic mutation, and another with a locally advanced rectal tumor treated with preoperative chemoradiation followed by surgery.
The document summarizes a study on CD24 expression and its role in male urothelial tumorigenesis and metastasis. The study found that:
1) Loss of CD24 was associated with reduced bladder tumor incidence and protected the bladder urothelium from tumorigenesis in mice exposed to a carcinogen.
2) Bladder tumors had higher levels of CD24 mRNA and protein expression than non-cancerous tissue.
3) Loss of CD24 decreased metastasis in male mice and appeared protective against tumorigenesis and metastasis specifically in males.
4) CD24 expression was found to be androgen-regulated, with androgens increasing CD24 expression at the mRNA and
The document discusses a study on CD24 expression in bladder tumorigenesis and metastasis in mice. The study found that loss of Cd24a is associated with reduced tumor incidence in OH-BBN-induced bladder tumors in mice. Cd24a expression was higher in bladder tumors than normal tissue. Loss of Cd24a protected bladder tissue from tumorigenesis and decreased metastasis in male mice. The study also found that CD24 expression is androgen-regulated, and promotes tumor growth and is a prognostic factor for disease-free survival in male patients with bladder cancer.
A 23-year old female presents with a rash, bruising, nosebleeds, and heavy menstruation. Her physical exam and labs reveal an isolated thrombocytopenia. Her peripheral smear shows decreased platelet numbers and slightly larger platelets, suggesting early release from the bone marrow in response to peripheral destruction. Further history and testing are needed to determine the cause of the thrombocytopenia.
This document discusses research into the role of the Bmi1 gene in tongue squamous cell carcinoma (TSCC). The study evaluated Bmi1 expression in 77 TSCC tumor samples and its impact on cancer cell migration and invasion. The results showed high Bmi1 expression in TSCC tissues and cell lines. Silencing Bmi1 using siRNA inhibited the migration and invasion of TSCC cells. Additionally, the study found that Bmi1 expression may be regulated by the C-myc oncogene and that both Bmi1 and C-myc regulate genes involved in cell proliferation and metastasis. This research provides insights into how Bmi1 contributes to TSCC development and progression.
The document discusses diffuse large B-cell lymphoma (DLBCL), its subtypes and classification. It describes how DLBCL can be categorized based on site of origin, characteristic features, association with viruses, or remain unclassified. Gene expression profiling can further distinguish DLBCL subgroups with different prognosis. The presence of MYC rearrangement or double hit lymphomas involving MYC and BCL2/BCL6 translocations predicts a very aggressive clinical outcome.
This document discusses modern treatment strategies for diffuse large B-cell lymphoma (DLBCL). It summarizes that DLBCL is molecularly distinct diseases with different biological characteristics and outcomes. Targeted therapies like ibrutinib and lenalidomide show promise for the activated B-cell (ABC) subtype of DLBCL. Monitoring circulating tumor DNA is presented as a very promising tool for early detection of treatment failure or recurrence, which can allow for pre-emptive treatment changes or early intervention.
Tumour markers can play a crucial role in detecting cancer and assessing response to therapy. They are substances produced either by tumour cells or by the body in response to cancer. Oncoproteins are proteins encoded by oncogenes which normally maintain a fine balance between cell proliferation and differentiation but become permanently activated in cancer, stimulating cell growth. Elevated levels of various oncoproteins and other tumour markers can be detected in blood and other body fluids, serving as biomarkers for early cancer detection and prediction of prognosis. Common tumour markers discussed include AFP, CEA, CA19-9, CA15-3, CA125, and proteins associated with growth factors, receptors, and cellular signalling pathways.
This document contains summaries of several topics related to immunobiology and cancer, including lymph formation and functions, inhibition of tumor-induced T cell anergy, generating cytolytic memory T cells, STAT3 activation in diffuse large B cell lymphoma, microbial control of intestinal innate immunity, spatiotemporal dynamics of Rho GTPases in cancer invasion, the role of macroH2A1 in cancer and senescence, epigenetic regulation of cancer by DNA methylation enzymes, targeting epigenetics in anticancer approaches, bladder cancer as a model for translational medicine, biology and treatment of prostate cancer, and personalized cancer medicine.
The document discusses several key hallmarks of cancer cells including evading apoptosis, achieving limitless replicative potential through telomerase activation, inducing angiogenesis, and developing the ability to invade locally and metastasize. It describes the intrinsic and extrinsic pathways of apoptosis evasion in cancer cells as well as mechanisms of telomere maintenance, angiogenesis induction, extracellular matrix degradation, vascular dissemination, and homing to distant sites.
This document summarizes the use of the nematode C. elegans as a model organism for studying human diseases. It discusses how CRISPR/Cas9 can be used to introduce disease-related mutations into C. elegans to model retinitis pigmentaria, cancer, and responses to chemotherapy. Drug screens and RNAi screens in these mutant worms have identified genetic modifiers and potential drug targets for treating human diseases. The small size, rapid life cycle, and genetic tractability of C. elegans make it a valuable pre-clinical model for validating targets and precision medicines before testing in mammalian systems.
This document discusses mature lymphoproliferative disorders. It covers their classification, stages of maturation, B-cell development and lymphomagenesis. Molecular features of lymphomas include genetic alterations, infection, antigen stimulation and immunosuppression. Chromosomal translocations can activate proto-oncogenes by juxtaposing regulatory sequences. Tumor suppressor genes are also inactivated through deletion and mutation. Somatic hypermutation may introduce genetic changes involved in lymphomagenesis.
- Compared to healthy controls, pancreatic cancer patients had significantly higher levels of total microparticles (MPs) and phosphatidylserine exposed MPs in their plasma.
- When perfused through an engineered microvessel network, only pancreatic cancer patients' plasma caused a significant number of MPs to adhere to the endothelial cells lining the vessels.
- Perfusing MPs derived from pancreatic cancer cells or cancer patients' plasma through the microvessels activated the endothelial cells, resulting in their increased release of endothelial cell-derived MPs.
This document provides an overview of neoplasia and the etiology of cancer. It discusses the three classes of carcinogenic agents: chemicals, radiant energy, and microbial agents. It describes chemical carcinogenesis as a multistep process involving initiation, promotion, and progression. Specific chemical carcinogens like polycyclic aromatic hydrocarbons and their mechanisms are explained. Radiation carcinogenesis and viral/microbial oncogenesis involving viruses like HPV, HBV, EBV, and HTLV-1 are summarized. Host defense against tumors through tumor immunity and tumor antigen classification is briefly covered.
Cancer is caused by genetic mutations from carcinogens like chemicals, radiation, and viruses. Cancer cells show uncontrolled growth, loss of contact inhibition, and altered biochemistry. Tumor markers are proteins produced by or in response to cancer that can help detect and monitor cancers. Common tumor markers include AFP for liver cancer, CEA for colorectal cancer, and PSA for prostate cancer.
Liver cancer is the fifth most common cancer and the second leading cause of cancer death globally. Hepatocellular carcinoma (HCC) represents about 90% of primary liver cancers. Major risk factors for HCC development include cirrhosis, viral hepatitis, toxins like alcohol and aflatoxins, metabolic conditions, and genetic disorders. Diagnosis involves non-invasive testing of tumor markers like AFP, AFP-L3, DCP, and imaging, or invasive biopsy. Surgical resection offers the best chance of cure for eligible early-stage patients with small tumors, while other treatments include cryosurgery, transplantation, and immunotherapy.
This document discusses biliary tract cancers including cholangiocarcinoma and gallbladder cancer. It provides information on risk factors, pathogenesis, clinical presentation, diagnostic evaluation, staging systems, and treatment options. Biliary tract cancers are generally diagnosed at late stages and have a poor prognosis. Surgical resection remains the only potentially curative treatment option, but palliative approaches are used for non-resectable disease.
Myeloid CCN3 protects against aortic valve calcifcation.pdfMafeOliveros3
This document summarizes a study that investigated the role of macrophage-derived CCN3 in the progression of calcific aortic valve disease. The study used techniques like immunofuorescence, PCR, Western blot, and ELISA to analyze CCN3 levels and interactions with other proteins in normal and calcified aortic valves. Results found CCN3 and other proteins like CD68, BMP2, and Vimentin present in calcified valves. The conclusion is that molecular biology techniques have helped further understanding of pathologies and development of diagnoses and treatments.
Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner ...home
These observations delineate the significance of immuno-modulatory circuit during calcarea carbonicamediated
tumor apoptosis. The molecular mechanism identified may serve as a platform for involving calcarea
carbonica into immunotherapeutic strategies for effective tumor regression
This document provides an overview of hepatic and pancreatic tumors. It discusses the clinical anatomy and physiology of the liver and pancreas. It describes different types of benign hepatic tumors like hemangiomas, adenomas, and focal nodular hyperplasia. For malignant hepatic tumors, it discusses hepatocellular carcinoma and cholangiocarcinoma. It covers the epidemiology, investigations, and management options for these tumors. For the pancreas, it discusses anatomy, physiology, tumor types including neuroendocrine tumors, and the management of pancreatic tumors through surgery or palliation.
The document discusses several topics related to colorectal cancer including hereditary forms, staging, treatment with surgery and targeted therapies. It presents two case studies, one with a family history of colon cancer who was found to have a genetic mutation, and another with a locally advanced rectal tumor treated with preoperative chemoradiation followed by surgery.
The document summarizes a study on CD24 expression and its role in male urothelial tumorigenesis and metastasis. The study found that:
1) Loss of CD24 was associated with reduced bladder tumor incidence and protected the bladder urothelium from tumorigenesis in mice exposed to a carcinogen.
2) Bladder tumors had higher levels of CD24 mRNA and protein expression than non-cancerous tissue.
3) Loss of CD24 decreased metastasis in male mice and appeared protective against tumorigenesis and metastasis specifically in males.
4) CD24 expression was found to be androgen-regulated, with androgens increasing CD24 expression at the mRNA and
The document discusses a study on CD24 expression in bladder tumorigenesis and metastasis in mice. The study found that loss of Cd24a is associated with reduced tumor incidence in OH-BBN-induced bladder tumors in mice. Cd24a expression was higher in bladder tumors than normal tissue. Loss of Cd24a protected bladder tissue from tumorigenesis and decreased metastasis in male mice. The study also found that CD24 expression is androgen-regulated, and promotes tumor growth and is a prognostic factor for disease-free survival in male patients with bladder cancer.
A 23-year old female presents with a rash, bruising, nosebleeds, and heavy menstruation. Her physical exam and labs reveal an isolated thrombocytopenia. Her peripheral smear shows decreased platelet numbers and slightly larger platelets, suggesting early release from the bone marrow in response to peripheral destruction. Further history and testing are needed to determine the cause of the thrombocytopenia.
This document describes research using a humanized mouse model to study hepatocellular carcinoma (HCC) associated with hepatitis C virus (HCV) infection. Key findings include the observation that HCV infection is associated with inactivation of tumor suppressors like PTEN and DLC-1, as well as induction of oncoproteins like c-Myc. HCV infection also decreased levels of p21 and increased levels of inflammatory markers like phosphorylated STAT3. Certain microRNAs like miR-141, miR-21 and miR-221 that can promote cancer were also found to be elevated in HCV-associated HCC in this model. The study provides insights into molecular changes underlying HCV-related liver cancer progression.
This document presents an unusual case of hepatocellular carcinoma (HCC) that metastasized to an extrahepatic site in the chest wall of a 60-year-old male patient. Key findings included a mass in the chest wall, hepatomegaly, and imaging showing a heterogenous liver lesion. The patient's HCC was determined to be at an advanced BCLC stage C despite the unusual metastatic site and lack of cirrhosis. Treatment with the multi-kinase inhibitor sorafenib and palliative radiation was recommended based on the literature review of HCC risk factors, staging systems, and standard of care treatments.
Oncogenes can reprogram tumor cells early in cancer development, establishing tumor-specific cell fates. This tumoral stem cell reprogramming hypothesis proposes that oncogenic lesions act on stem/progenitor cells, imposing a specific tumor-differentiated cell fate. Experimental evidence in mouse models of chronic myeloid leukemia and multiple myeloma support this hypothesis by showing oncogene expression restricted to stem cells results in cancer. This challenges the classical view that oncogenes uniformly alter differentiated cells and suggests reprogramming cancer stem cells could be a therapeutic target.
This document summarizes key information about hepatocellular carcinoma (HCC). It discusses the etiology and pathogenesis of HCC. It describes the role of tumor tissue analysis in diagnosing HCC and assessing prognosis. Gross morphology, histological subtypes, and morphological parameters are reviewed. The importance of distinguishing HCC from other nodular lesions and metastases is covered. Biomarkers and the role of liquid biopsies are also mentioned.
The document discusses peritoneal surface malignancy and its treatment with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). It covers the principles, indications, staging, procedures, complications and outcomes of CRS and HIPEC. Key points include that CRS aims to remove all visible tumor followed by HIPEC to treat microscopic disease. Complete cytoreduction to no visible tumor or less than 2.5mm results in better survival. Major complications occur in 30-45% of cases but mortality is low at 0-5%. CRS and HIPEC provide long-term survival for select patients with peritoneal carcinomatosis from various primary cancers.
This study found that colon cancer cells express the chemokine receptor CCR4, which mediates migration of the cells in response to its ligand CCL17 (TARC) through the RhoA/Rho kinase signaling pathway. Quantitative RT-PCR and flow cytometry showed that the colon cancer cell lines HT-29 and AZ-97 expressed CCR4 at both the mRNA and protein levels. Stimulation with CCL17 induced dose-dependent migration of the colon cancer cells, which was inhibited by blocking CCR4 with an antibody or antagonist. CCL17 also increased mRNA levels of RhoA proteins and RhoA activation in the cells. Inhibition of Rho kinase or isoprenylation blocked CCL17-induced cell migration
Genistein (GEN) treatment reduces cytoplasmic levels of the anti-apoptotic protein Bcl-xL and increases nuclear Bcl-xL levels in non-small cell lung cancer (NSCLC) cells. Low cytoplasmic Bcl-xL levels are associated with increased sensitivity to ionizing radiation (IR) treatment in NSCLC cell lines and patient samples. GEN enhances the effects of IR by promoting apoptosis and autophagy through reducing cytoplasmic Bcl-xL, increasing DNA damage, and promoting dissociation of Bcl-xL from Beclin-1 to activate Beclin-1-mediated autophagy. The combination of GEN and IR shows synergistic inhibition of NSCLC cell viability
This document summarizes a clinical trial investigating the addition of celecoxib, a COX-2 inhibitor, to standard chemotherapy for stage IIIB/IV NSCLC. Preclinical and epidemiological evidence suggests COX-2 inhibitors may have antitumor and chemopreventive effects in lung cancer. The trial will randomize patients to receive carboplatin, gemcitabine and either celecoxib or placebo. The primary objective is to determine if celecoxib improves progression-free and overall survival compared to placebo in COX-2 overexpressing NSCLC. Secondary objectives include confirming the prognostic value of COX-2 expression and exploring correlations between biomarkers and outcomes.
Biotweeps conference:
RNA sequencing-based cell proliferation analysis across 19 cancers identifies a subset of proliferation-informative cancers with a common survival signature
This document discusses various malignant liver lesions including primary and secondary tumors. For primary liver cancers, it describes hepatocellular carcinoma (HCC) as the most common type, risk factors such as hepatitis, and imaging features. It also discusses cholangiocarcinoma, hepatoblastoma, and rare tumors such as fibrolamellar carcinoma. Secondary cancers and criteria for staging HCC are also summarized.
This patient presented with rectal bleeding and weight loss and was found to have stage III adenocarcinoma. Given his family history of colorectal cancer in a first-degree relative at a young age, he is at high risk for hereditary non-polyposis colorectal cancer (HNPCC). HNPCC accounts for 5-7% of colorectal cancers and results from a mutation in DNA mismatch repair genes. Individuals with HNPCC have an increased lifetime risk of colorectal and other cancers. The patient was counseled on genetic testing and increased screening for relatives is recommended.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
3. INTRODUCTION
Colorectal cancer (CRC):
Is the third most commonly
diagnosed malignancy in the world.
It still constitutes the fourth leading
cause of cancer-related deaths.
It is a common, lethal, and
prevalent tumor.
CRC-related deaths are
secondary to progression of the
disease and metastases.
5. OBJECTIVE
.
Analyze the Haploinsufficiency of Casitas
B-Lineage Lymphoma Augments the
Progression of Colon Cancer in the
Background of Adenomatous Polyposis
Coli Inactivation
8. INMUNO
HISTOQUÍMICA
- Tecnica que se basa en una
reaccion entre un antigeno y un
anticuerpo para determinar la
presencia de proteinas celulares.
- Esa reaccion se da sobre un
tejido que es identificada por
medio de un anticuerpo
marcado.
9. With genetic engineering,
we will be able to increase the
complexity of our DNA, and
improve the human race.
Stephen Hawking
RT-PCR of
CBL mRNA
- Se produjo un cDNA
mediante la transcriptasa
inversa
-RNeasy mini kit
- Se midió la concentración
de ese ARNm de cCBL por la
PCR en tiempo real
10. WESTERN
BLOT
-Detecta la cantidad de proteina
expresada al interactuar con un
antigeno especifico
-Luego se miden por una
electroforesis en gel para mirar
la expresión del gen CBL
+/+ HOMOCIGOTO
+/- HETEROCIGOTOGráficas:
12. Figura 2
A) Los ratones muestran
tumorigénesis espontánea en su
intestino delgado y grueso.
GRÁFICA:
APC 14/+ CBL +/+ homocigotico
APC 14/+ CBL +/- hetorocigotico.
13. Figura 2
C) Los lisados de los testículos
mostraron hasta un 50% de
reducción de la proteína c-Cbl
en los ratones heterocigoticos
14. Figura 2
D) La expresión c-Cbl se redujo
en el epitelio colónico,
especialmente en las células en
los ápices de las criptas
15. Hiperplasia atipica de
intestino delgado
Adenocarcinoma en:
Intestino grueso y
delgado
APC14+/+ c-CBL Homocigoto
APC14-/+ c-CBL Heterocigoto
GRÁFICA:
HAPLOINSUFICIENCIA
16. Analizar el axin2 con
quien interactua la b-
catenina potenciando
su acción en la vía de
señalización Wnt
Flecha amarilla :Citosol
Flecha blanca: núcleo
18. In combination with
previous data, this work
supports the notion that c-
Cbl down-regulates two
key components of
CRCepithelial
tumorigenesis and tumor-
induced angiogenesis
However, further studies are
needed to elucidate
potential underlying
mechanisms that
compensate for the loss of
ubiquitin ligase, which are
known to undergo
autoubiquitination or
deubiquitination
1.Rahimi N (41)
2. De Bie P,
Ciechanover A
(38)
19. 3. Shasar M (10) In CRC cells, c-Cbl
suppresses the growth of
colon cancer cells by
down-regulating Wnt
signaling and suppressing
nuclear b-catenin
20. CONCLUSION
We conclude that the detection and quantification of
genetic material has shown a great impact in the area of
health, mainly in oncology. The development of tests has
transformed molecular diagnosis into a key tool for the
treatment of future patients.
1.
2. The application of molecular biology has allowed an
important advance in the knowledge on the pathophysiology
of conditions generated by genetic alterations.
21. 3. The ability to generate molecular methods is an interesting
alternative to study, since it allows to know and understand in
a wider way as this possible genetic defect, can become a
specific phenotype.